Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
Anti-infective agent
Antimicrobial agent
Clinical pharmacist
Cost analysis
Critical care
Critically ill
Journal
Research in social & administrative pharmacy : RSAP
ISSN: 1934-8150
Titre abrégé: Res Social Adm Pharm
Pays: United States
ID NLM: 101231974
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
07
07
2019
accepted:
07
07
2019
pubmed:
23
7
2019
medline:
29
7
2021
entrez:
23
7
2019
Statut:
ppublish
Résumé
Incorporating in the Intensive Care Unit (ICU) a clinical pharmacist who performs interventions on antimicrobials may be cost-effective. To evaluate the clinical and economic impact of clinical pharmacist interventions on antimicrobials in an ICU. To identify drug related problems and medication errors detected by the pharmacist. A retrospective observational study was performed to analyze drug related problems, medication errors and clinical pharmacist interventions related to antimicrobials in adults admitted to an ICU in a 5-month period. The economic impact of pharmacist interventions was estimated considering difference in cost derived from antimicrobial treatment, adverse drug events and clinical pharmacist time. A total of 212 drug related problems were detected in 114 patients, 18 being medication errors. Clinical pharmacist developed one intervention for each problem identified. 204 interventions (96.2%) were considered important with improved patient care and 7 (3.3%) very important. No negative impact of any intervention was identified. Physicians accepted 97.6% of the interventions. A potential saving of 10,905 € was estimated as a result of pharmacist interventions and 4.8 € were avoided per euro invested in a clinical pharmacist. A clinical pharmacist performing interventions on antimicrobials in the ICU has a positive impact on patient care and decreases costs.
Sections du résumé
BACKGROUND
BACKGROUND
Incorporating in the Intensive Care Unit (ICU) a clinical pharmacist who performs interventions on antimicrobials may be cost-effective.
OBJECTIVES
OBJECTIVE
To evaluate the clinical and economic impact of clinical pharmacist interventions on antimicrobials in an ICU. To identify drug related problems and medication errors detected by the pharmacist.
METHODS
METHODS
A retrospective observational study was performed to analyze drug related problems, medication errors and clinical pharmacist interventions related to antimicrobials in adults admitted to an ICU in a 5-month period. The economic impact of pharmacist interventions was estimated considering difference in cost derived from antimicrobial treatment, adverse drug events and clinical pharmacist time.
RESULTS
RESULTS
A total of 212 drug related problems were detected in 114 patients, 18 being medication errors. Clinical pharmacist developed one intervention for each problem identified. 204 interventions (96.2%) were considered important with improved patient care and 7 (3.3%) very important. No negative impact of any intervention was identified. Physicians accepted 97.6% of the interventions. A potential saving of 10,905 € was estimated as a result of pharmacist interventions and 4.8 € were avoided per euro invested in a clinical pharmacist.
CONCLUSIONS
CONCLUSIONS
A clinical pharmacist performing interventions on antimicrobials in the ICU has a positive impact on patient care and decreases costs.
Identifiants
pubmed: 31327737
pii: S1551-7411(19)30663-1
doi: 10.1016/j.sapharm.2019.07.006
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1285-1289Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.